EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gene mutations as a non-invasive measure of adult cochlear implant performance: Variable outcomes in patients with select TMPRSS3 mutations

Justin Cottrell iD, Peter Dixon, Xingshan Cao, Alex Kiss, Kari Smilsky, Kassandra Kaminskas, Amy Ng, David Shipp, Andrew Dimitrijevic, Joseph Chen, Vincent Lin, Lianna Kyriakopoulou und 1 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0291600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Justin Cottrell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Cochlear Implants, Cochlear Implantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The cochlear implant (CI) has proven to be a successful treatment for patients with severe-to-profound sensorineural hearing loss, however outcome variance exists. We sought to evaluate particular mutations discovered in previously established sensory and neural partition genes and compare post-operative CI outcomes. Materials and methods Utilizing a prospective cohort study design, blood samples collected from adult patients with non-syndromic hearing loss undergoing CI were tested for 54 genes of interest with high-throughput sequencing. Patients were categorized as having a pathogenic variant in the sensory partition, pathogenic variant in the neural partition, pathogenic variant in both sensory and neural partition, or with no variant identified. Speech perception performance was assessed pre- and 12 months post-operatively. Performance measures were compared to genetic mutation and variant status utilizing a Wilcoxon rank sum test, with P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cochlear ImplantsCochlear ImplantationHumansAdultProspective StudiesMutationGenetic TestingMembrane ProteinsNeoplasm ProteinsSerine Endopeptidases

Substanzen

TMPRSS3 protein, humanMembrane ProteinsNeoplasm ProteinsSerine Endopeptidases

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Department of Research Design and Biostatistics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Department of Laboratory Medicine & Pathology-Clinical Chemistry, Hospital for Sick Children, Toronto, Ontario, Canada.

ORCID-Profile: Justin Cottrell, Trung Le

Zitieren

APA

Cottrell, J., Dixon, P., Cao, X., Kiss, A., Smilsky, K., Kaminskas, K., Ng, A., Shipp, D., Dimitrijevic, A., Chen, J., Lin, V., Kyriakopoulou, L., & Le, T. (2023). Gene mutations as a non-invasive measure of adult cochlear implant performance: Variable outcomes in patients with select TMPRSS3 mutations. PLOS ONE. https://doi.org/10.1371/journal.pone.0291600

Vancouver

Cottrell J, Dixon P, Cao X, Kiss A, Smilsky K, Kaminskas K, et al. Gene mutations as a non-invasive measure of adult cochlear implant performance: Variable outcomes in patients with select TMPRSS3 mutations. PLOS ONE. 2023. doi:10.1371/journal.pone.0291600

BibTeX
@article{Cottrell2023,
  author = {Cottrell, Justin and Dixon, Peter and Cao, Xingshan and Kiss, Alex and Smilsky, Kari and Kaminskas, Kassandra and Ng, Amy and Shipp, David and Dimitrijevic, Andrew and Chen, Joseph and Lin, Vincent and Kyriakopoulou, Lianna and Le, Trung},
  title = {Gene mutations as a non-invasive measure of adult cochlear implant performance: Variable outcomes in patients with select TMPRSS3 mutations},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0291600}
}
Kostenlos starten →